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Abstract.  The extracellular matrix (ECM) is an im- 
portant regulator of the differentiated phenotype of 
mammary epithelial cells in culture. Despite the fact 
that ECM-degrading enzymes have been implicated in 
morphogenesis and tissue remodeling, there is little 
evidence for a direct role for such regulation in vivo. 
We generated transgenic mice that express autoacti- 
vated isoforms of the matrix metalloproteinase 
stromelysin-1, under the control of the whey acidic 
protein gene promoter, to examine the effect of inap- 
propriate expression of this enzyme. Stromelysin-1 is 
implicated as the primary player in the loss of base- 
ment membrane and loss of function in the mammary 
gland during involution. The transgene was expressed 
at low levels in maramary glands of virgin female 
mice, leading to an unexpected phenotype: The pri- 
mary ducts had supernumerary branches and showed 
precocious development of alveoli that expressed 
/3-casein at levels similar to that of an early- to mid- 
pregnant gland. Lactating glands showed high levels of 
transgene expression, with accumulation at the base- 
ment membrane, and a decrease in laminin and colla- 
gen IV, resulting in a loss of basement membrane in- 
tegrity; this was accompanied by a dramatic alteration 
of alveolar morphology, with decreased size and 
shrunken lumina containing little/3-casein. During 
pregnancy, expression of endogenous whey acidic pro- 
tein and r-casein was reduced in transgenic glands, 
confirming the observed dependence of milk protein 
transcription on ECM in mammary epithelial cells in 
culture. These data provide direct evidence that 
stromelysin-1 activity can be morphogenic for mam- 
mary epithelial cells, inducing hyperproliferation and 
differentiation in virgin animals, and that its lytic ac- 
tivity can, indeed, disrupt membrane integrity and re- 
duce mammary-specific function. We conclude that the 
balance of ECM-degrading enzymes with their inhibi- 
tors, and the associated regulation of ECM structure, 
is crucial for tissue-specific gene expression and mor- 
phogenesis in vivo. 
T 
HE differentiated state is plastic, requiring continuous 
and active control for both its acquisition and its main- 
tenance (Bisseli, 1981; Blau, 1992). In vertebrate cells 
in culture, there is an increasing body of evidence that the 
extracenular matrix (ECM) t plays a seminal role both in in- 
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1. Abbreviations used in this paper: ECM, extracellular matrix; MMP, ma- 
trix metalloproteinase; SL-MI or M2, stromelysin-M1  or M2 autoactivat- 
ing construct; TIME tissue inhibitor of metalloproteinases; WAP, whey 
acidic protein. 
ducing and in maintaining the differentiated state,  particu- 
larly in epithelia  (Gmbstein,  1954; BisseU et al.,  1982; 
Damsky and Werb,  1992; Adams and Watt, 1993; Hay, 
1993; Juliano and Haskill,  1993), but the question of how 
tissue-specific gene expression is induced or maintained in 
vivo has not been elucidated (Schmidt et al.,  1993). 
Synthesis and secretion of  milk proteins by cultured mam- 
mary epithelial ceils has been shown to result from a hierar- 
chical series of events at the cellular level that involve hor- 
mones,  ceU-cell interactions,  and  ceI1-ECM interactions 
(for review see Lin and Bissell,  1993). In particular, the ex- 
pression of milk proteins is strongly regulated by interac- 
tions with the basement membrane. It appears that integrins 
may be used by mammary epithelial cells in culture for rec- 
ognition of ECM and regulation of tissue-specific  function 
(Streuli et al., 1991). Furthermore, novel enhancers that re- 
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specific  genes (Schmidhauser et al.,  1992). 
ECM remodeling  of the basement  membrane has been 
suggested as a mechanism of altering morphogenic tissue in- 
teraction (for review  see Bernfield et al.,  1984).  The key 
players in such a process are likely to be the ECM-degrading 
metallopmteinases  (for review  see  Alexander  and  Werb, 
1991; Birkedal-Hansen,  1993).  In particular, the basement 
membrane-degrading  matrix  metalloproteinases  (MMPs), 
including  stromelysin-l,  are implicated  as primary deter- 
minants that regulate the loss of nmnmmry function during 
involution (Talhouk et al.,  1991), because the implantation 
of slow-release  pellets  containing  the  tissue  inhibitor  of 
metalloproteinases  (TIMP)-I  delays involution (Talhouk et 
al.,  1992). 
To establish the validity of the concept that ECM regulates 
gene expression in vivo and to elucidate the molecular mech- 
anisms  involved,  we generated transgenic mice that inap- 
propriately express an autoactivating rat stromelysin-1 gene 
targeted to mammary gland under the control of the gene 
promoter for whey acidic protein (WAP), a milk protein that 
accumulates beginning  in midpregnancy (Hennighausen et 
al.,  1991).  We chose rat stromelysin-1 because,  first, this 
proteinase has a wide range of ECM substrates, including 
fibronectin,  lamlnin,  type IV collagen,  and proteoglycans 
(Chin et al., 1985); second, it is implicated in physiological 
control of mammary gland function during involution (Tal- 
houk et al.,  1992);  and third, autoactivating mutant con- 
structs for the proenzyme  form of stromelysin-1 have been 
generated  and  well  characterized  (Sanchez-Lopez  et  al., 
1988). We chose the WAP promoter because it has been used 
extensively  to target transgene expression to the mmnmm~ 
gland during midpregnancy and lactation with high fidelity 
and specificity (Pittius et al., 1988), thus avoiding artifactual 
results. 
Our experimental rationale was to alter the ratio of ECM- 
degrading proteinases to inhibitors in favor of the protein- 
ases in the presence  of the full lactational  stimulus.  Dur- 
ing pregnancy and lactation, proteinase inhibitors are more 
abundant than MMPs, and the gland is functionally differen- 
tiated (Talhouk et al.,  1992),  when the transgene should be 
expressed. Because the structure and biochemistry of mouse 
mammary gland are well understood, interpretation of mam- 
mary phenotype is straightforward, allowing subtle changes 
to be readily detected.  The transgenic mice we have pro- 
duced make it possible for us to address the effect of inap- 
propriate expression of these enzymes in the whole animal, 
where all the compensatory mechanisms are intact. We have 
discovered that these enzymes are morphogenic in an inter- 
active  mesenchymal-epithelial  developmental  system  and 
are thus important players in the signaling events that occur 
between these cell types. 
Materials and Methods 
Mammary Tissue 
Mammary tissue was  obtained from normal and transgeulc CD-I  mice 
(Charles River, Wilmin~on, MA) at various stages of development, as de- 
scribed previously (Talhouk et al., 1991, 1992). For all morphological anal- 
yses, left and right inguinal  (number 4) mammary glands were used.  All 
experiments were performed under protocols approved by the Animal Wel- 
fare and Research Committee,  I.atwrence Berkeley  Laboratory, and the 
Committee on Avimal Research, University of California, San Francisco. 
Generation of Tmnsgenic Mice 
The CAI0:SL:MI or CA10:SL:M2 vector (see Fig. 1 A), designed to direct 
expression of antoactive stmmelysin-1 to the mammary gland of pregnant 
and lactating mice, was assembled from portions of a 7.2-kb WAP mouse 
genomie DNA clone. A 2.4-kb EcoRI-Kpnl fragment containin~ the WAP 
gene promoter was subcloned into the Bluescript vector (Stratagem, La 
Jolla, CA) together with a linker region containino internal HindlH and SalI 
sites. A 2.8-kb 3' untranslated region SalI fragment, which included a por- 
tion of the last coding exon, the 3' intron, and the noncoding Y exon (with 
the polyadenylation signal) was then llsated 3' of the SalI linker, site tO form 
the CA10 vector. Previous studies with the WAP promoter suggest that thee 
regions of the gene are required for proper expression in vivo (Dale et al., 
1992). Specifically mutated eDNAs for rat stsomelysin-1 (transin-1) (con- 
tainin~ a Va192 ~  Gly  92 or Pro  93 ~  Va193 transition, M1 and M2, respec- 
tively), encoding an autoacfivafing enzyme, were subcloned as 1.8-kb in- 
serts  into  the  CA10  vector  at  the  l-lindlll elonin  8  site  to  form  the 
CA10:SL:M1 or M2 construct. The mouse WAP genomie DNA clone was 
kindly provided by L. Hennighausen (Pitfius ct al., 1988), and the two mu- 
tant rat stmmelysin-I eDNAs were kindly provided by R. Sanehez-Lopez 
and R. Breathnaeh (Sanchez-Lopez  et al.,  1988). 
Transgenie mice were generated  in the outhred CDq strain as described 
by Hogan et al. (1986). The CA10:SL:M1 and CA10:SL:M2 plasmids were 
purified on a  Waters  GenPak FAX  colunm (Millipore,  Bedford,  MA), 
resuspend.ed in Tris-EDTA buffer at 1-2 ng/mi, and microinjected into 1-cell 
fertilized eggs. The injected embryos were transferred into oviducts of re- 
cipient pseudopregmmt female CD-I mice, and the off,  spring were analyzed 
for the presence of  the transgene.  Of the 258 egSS injected with the MI con- 
struct, 129 were transferred to recipient pseudopregnant CD-I mice, and 
4 of 14 offspring contained the transgene. Likewise,  of 460 eggs injected 
with the M2 construct, 290 were transferred, and 8 of 27 o~pring con- 
tained the transgene. 
D NA Analysis 
To determine the relative abundance, integri~j, and presence of the WAP- 
stromelysin-1 transgene in the offspring, DNA was isolated from tail cuts, 
digested with EcoRI to generate the 1.8-kb insert, and analyzed by DNA 
blot analysis on nylon membranes (Hybond N+, Amersham  Corp., Arling- 
ton Heights, IL) as described by Reddy et al. (1991). The membranes were 
hybridized overnight at 680C to a random-primed 32P-rediolaboled 1.8-10o 
rat stromelysin-1 DNA isolated from an EcoRI digest of CA10:SL:M2.  The 
blots were washed twice for 15 rain each in 2× SSC 0× SSC  ffi 0.15 M 
NaCl, 0.015 M  sodium citrate)/0.2% SDS followed by a 30-min wash in 
0.1× SSC/0.1% SDS at 68"C before exposing to XAR-5 film (Eastman Ko- 
dak Co., Rochester,  NY) for fluorography  at -800C. 
RNA Preparation and Analysis 
Total RNA was prepared from mammary tissue or from enzymatically dis- 
sociated mouse mammary epithelial cells as described previously(Lee et 
al.,  1985). RNA samples were resolved on 1% agarose formaldehyde gels 
under denaturing conditions, transferred to nylon membranes (Hybond-N), 
and hybridized to 32p--dCTP random-primed radiolaboled mouse DNA 
probes. Blots withl or 2 pg total RNA were used for detection of/~-casein 
and WAP mRNA expression,  cDNAs for/~-casein (Riehards et al.,  1981) 
and WAP (Campbell et al., 1984) were kindly provided by J. Rosen, Bnylor 
College of Medicine, Baylor, TX, and L. Hennighausen, National Institutes 
of Health, Bethesda, MD,  respectively.  Prehybridization, hybridization, 
and posthybridization washes were carried out according to the method of 
Talhouk et al. (1992). 
Reverse Transcription-Polymerase Chain Reaction 
To examine the expression of the transgene, total RNA from normal and 
transgenic  mice was purified as described previously ('I~lhouk et al., 1992), 
equal amounts of total RNA (4/tg) were treated with DNase (amplification 
grade; Bethesda Research Laboratories), and 1 ~t  8 ~¢erse transcribed. Two 
sets  of nonspecific  rat/mouse stromelysin-1  primers with similar target 
sequences  of 201 bp and 207 bp were then used to amplify 120 n8 of the 
resulting eDNA by PCR:  5' ~TTC~ItIGKIUAGA,  3' 
ACCAGCTGTTGCTCTI'CAATATGTG  and 5' CTGGAGGTTrGATGAG- 
AAGA,  3' AAACCAGCTGTTGCTCTICA,  respectively.  Unl!ke the rat 
stromelysin-l,  mouse stromelysin-1 does not contain a Baml-H recognition 
sequence in this region. Equal volumes of the resulting PCR reaction prod- 
ucts were then digested with BamI-H restriction enzyme to yield two frag- 
ments of 169-bp and 38-bp, respectively,  from the rat stromelysin-1 tram- 
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visualized by ethidium bromide staining. 
Histology and Immunocytochemistry 
Whole-mount staining of the mammary gland (Medina,  1973)  was per- 
formed by fixing the flattened lnammary gland tissue overnight in Caraoy's 
solution (75 % ethanol; 25 % glacial acetic acid). After brief dehydration in 
70% ethanol, the gland was stained overnight in carmine alum (0.2% car- 
mille dye [wtJvol] and 0.5% aluminum potassium sulfate [wt/vol]).  Once 
dehydrated in increasing concentrations of ethanol, the gland was defatted 
in toluene and placed in methyl salicylate for loag-term storage.  Examina- 
tion and photography of the whole-mount stained glands were performed 
on a Wild Leitz dissecting microscope.  To count end buds and determine 
branching frequency,  calibrated slides of whole-mount glands were pro- 
jected and measured. 
Immunofluorescence staining for type IV collagen,  laminin, and/5-cas- 
ein was performed on frozen sections.  Mammary tissue was embedded in 
Tissue-Tek OCT compound (Miles Diagnostic Division, Elkhart, IN) and 
frozen in an ethanol/dry ice bath. Sections (4 ,¢m) were cut with a Leitz 
cryotome, placed on gelatin-coated slides,  and stained by immunottuores- 
cence (Harlow and Lane, 1988) as described by Talhouk et al. 0992). Poly- 
clonal rabbit antisera to mouse laminirl (E.Y. Labs, San Marco, CA) and 
type IV collagen were used at a 1:300 dilution and detected by staining with 
biotinylated anti-rabbit IgG (Amersbam Corp.)  followed  by Texas red- 
streptavidin, which were used at 1:50 dilution and 1:2,000 dilution, respec- 
tively, for 30 rain each at ambient temperature.  For detection of/~-¢asein, 
mouse monoclonal antibody to rat E-casein (gift of C. Kaetzel, Case West- 
era Reserve University, Cleveland, OH) was FITC-conjugeted  (Harlow and 
Lane, 1988) and used at a dilution of 1:50. Zeiss epifluoresceoce optics and 
Tri-X-400  film (Eastman Kodak Co.) were used. 
FOr stromelysin-1 immunocytochemistry,  and for hematoxylin and eosin 
staining: paraffin-embedded  sections were used.  Mammary glands were 
fixed in 4 % paraformaldehyde,  dehydrated in 30% ethanol followed by 70 % 
ethanol, and embedded in paraffin.  Sections  (4/~m) were stained with he- 
matoxylin and eosin or stained for stromelysin-1 as described by Talhouk 
et al. 0992). Monoclonal mouse anti-human stromelysin-1 antibody (clone 
SL 188.2, used at 5 ~g/ml in blocking buffer), a gift from S. M. Wtlhelm, 
Miles Research Center, West Haven, CT (Wilhelm et al., 1992), was previ- 
ously shown to react with mouse stromelysin-1  (Talhouk et al.,  1992). Its 
reaction with rat stromelysin-1  was confirmed by immunoblot analysis  of 
conditioned medium after expressing a CMV promoter-drivan expression 
vector containing SL:M2 in Comma D cells (unpublished observation). 
Alkaline pbosphatase-conjugated streptavidin (1:100) was used to localize 
stromelysin-I by alkaline phosphatase substrate (ABC kit, Vector Labs., 
Burlingame, CA).  Endogenous  alkaline phospbatase activity was blocked 
by levamisole  (Sigma Chem. Co., St.  Louis, MO). 
Protein Blotting 
For preparation of samples,  freshly isolated mammary tissue was immedi- 
ately frozen in liquid nitrogen. The tissue was then pulverized to a fine pow- 
der, weighed, and either stored at -70"C or suspended  1:5 (wt/vol) in ex- 
traction buffer (1% Triton X-100, 500 mM Tris-HCl, pH 7.6, 200 mM NaCI, 
and 10 mM CaC12). The suspension was frozen on dry ice,  thawed four 
times, and then centrifuged at 12,000 g for 30 rain at 4"C; the superaatant 
and pellet fractions were removed and stored at -70"C. Samples from the 
Triton-insoluble pellet fractions,  containing the basement membrane com- 
ponents, were resolved on 12 % SDS-polyacrylamide  gels under denaturing 
conditions for Coomassie blue staining to ensure equal loading of the sam- 
ples, and on 7%  SDS-polyacrylamide  gels for transfer to Immobilon-P 
membranes (Millipore Continental Water Systems,  Bedford,  MA) with a 
dry blot apparatus (American Bionetics,  Hayward,  CA). Membranes were 
incubated overnight in a wash buffer (100 mM Tris-HC1, pH 7.5, 150 mM 
NaCI, 0.3% Tween 20) containing 2% fatty acid-free BSA (Sigma Chem. 
Co~). The membranes were then incubated for 1 h with polyclonal  rabbit 
anti-mouse laminin or type IV collagen antibodies (diluted 1:300 in block- 
ing buffer) and washed three times, for 20 rain each, to remove unbound 
proteins. Bound antibody was detected by addition of alkaline phospbatase- 
conjugated  anti-rabbit IgG (Caltag Labs., South San Francisco, CA), fol- 
lowed  by BCIP/NBI"  (bromo-chloro-indolyl phosphate/nitroblue tetrazo- 
lium; Sigma). All washings and incubations were done at ambient tempera- 
ture.  Extracts of ECM from the mouse Engelbreth-Holm-Swarm sarcoma 
were also blotted in parallel with tissue extract samples as controls for base- 
ment membrane components.  Biotinylated size markers were detected with 
the use of alkaline phosphatase-conjugated streptavidin (Zymed Labs., San 
Francisco,  CA). 
Results 
The WAP Promoter Targets the Stromelysin-1 
Transgene to Mammary Gland 
We  constructed  two  plasmids,  CA10:SL:M1  and  CA10: 
SL:M2, containing  2.4 kb of the WAP promoter and 2.8 kb 
of  the  3'  untranslated  region  linked  to  the  mutant 
stromelysin-1 cDNAs (Fig.  1 A). These regions of the WAP 
gene have been shown to be absolutely necessary for proper 
regulation  and  maximum  expression  of the  endogenous 
mouse WAP gene (Dale et ai., 1992). The two rat stromely- 
sin-1 cDNA constructs used were mutated in the highly con- 
served psSRCGVPDV  95 segment near the amino-terminus  of 
the proenzyme sequence (Sanchez-Lopez  et ai., 1988; Park 
et al., 1991). As a result, these stromelysin-1 enzyme activi- 
ties are independent of the presence of activators.  The M1 
and M2 mutations contain a  Va192 ~  Gly  92 or a  pro93 
Va193 transition,  respectively,  with the M2 mutant strome- 
lysin-1 protein displaying  faster kinetics  of activation  than 
the M1 (Sanchez-Lopez  et ai., 1988). Eight SL-M2 founder 
mice  (F0)  were  generated.  Two  of the  seven  surviving 
founder mice that  showed the highest copy number,  M2-5 
and M2-21 (Fig.  1 B), were bred further and their offspring 
characterized  for expression  of the  transgene  and  conse- 
quences of such expression.  Four SL-M1 founder mice were 
generated, of which a single viable founder, M1-9, survived. 
The M2-5,  M2-21,  and M1-9 heterozygotes all had similar 
phenotypes (as described below). 
Tissues  from transgenic  mice were examined  by reverse 
transcription-PCR for tissue-specific expression of the stro- 
melysin-1 transgene.  The stromelysin-1  transgene  was ex- 
pressed in mammary glands of pregnant  female mice (Fig. 
1 C) and at low levels in brain, but not in liver, kidney, skin, 
or Harderian gland  (data not shown). The expression  of a 
WAP  transgene  in  brain  has  been  described  previously 
(Gunzburg et ai., 1991). The transgene was not expressed in 
mammary glands of adult male transgenic  mice. The trans- 
genie mice expressed both the rat stromelysin-1  transgene 
mRNA and  the endogenous mouse  stromelysin-1  mRNA 
(Fig.  1 C). The endogenous gene was expressed at all stages 
of nmnmm~  gland  development,  although  expression was 
by far the highest in involution (Talhouk et ai.,  1992). Sur- 
prisingly,  the transgene  was expressed at low levels in adult 
(70-d-old) female virgin mammary gland. As expected from 
the activity of the WAP promoter, expression of the trans- 
gene increased in late pregnancy and lactation and decreased 
during  involution, when normalized to the RNA present in 
the whole gland. Because total RNA and mRNA in mam- 
mary gland increase 100-fold over the course of pregnancy 
and  another  10-fold  during  early  lactation  (Nakhasi  and 
Quasba, 1979), we consider the total expression of  the trans- 
gene to have increased at least 100-1,000-fold  during preg- 
nancy and lactation. 
Although  little endogenous stromelysin-1 protein was de- 
tected by immunocytochemistry during  lactation  in mam- 
mary tissue from normal mice (Fig. 2 A), there was abundant 
stromelysin-1 protein in transgenic  manunary tissue,  local- 
ized to the proximity  of the basement membrane surround- 
ing the aiveoli (Fig. 2 B). By in situ hybridization,  the ex- 
pression of endogenous stromelysin was confined to walls of 
blood vessels (data not shown). These data support the con- 
clusion that at least some of the transgenic protein is secreted 
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of the WAP genomic DNA clone 
and the CA10:SL:MI or M2 cow 
struct (containing the mutant rat 
stromelysin-1 1.8-kb cDNA insert 
{M1 or M2} flanked by the 2.4-kb 
WAP  promoter  and  the  2.8-kb 
WAP 3' untranslated  region).  Re- 
striction  sites  were described by 
Campbell  et  al.  (1984)  and 
confirmed  for  this  study:  B, 
BamHI; R,  EcoRI; H,  HindRI; 
K,  KpnI;  P,  PstI;  S,  SalI;  Xb, 
XbaI;  ~,  XhoI.  (B)  Southern 
blot analysis of DNA from trans- 
genic mice.  10 #g of tail  DNA 
from  transgenic  founder  (F0) 
mice was digested  with  EcoRI, 
transferred  to a nylon membrane, 
and  hybridized  to  a  random 
primed  32p-labeled  rat  stro- 
melysin-1  cDNA.  The  1.8-kb 
band  is  indicative  of the  stro- 
melysin-1  DNA  fragment.  As- 
terisks  indicate  the  two  lines, 
M2-5  and  M2-21,  that  were 
characterized  and  used  in  these 
studies.  (C)  Expression  of the 
stromelysin-1  transgene in trans- 
genic  mice.  RNA  (4  #g)  from 
70-d  virgin  (V),  15-d-pregnant 
(P),  8-d-lactating  (L),  and 9-d- 
lactating/2-d-involuting  (I) trans- 
genic  mice  was  treated  with 
DNase  and  reverse-transcribed, 
and 120 ng was amplified by PCR 
with  nonspecific  rat/mouse 
stromelysin-I  primers.  Equal 
amounts  of  the  resulting  am- 
plified cDNA were digested with 
BamHI,  resolved  on  a  4% 
agarose  gel,  and  visualized  by 
ethidium  bromide  staining.  Al- 
though the primers amplified both 
endogenous  mouse  and  trans- 
genic  rat  stromelysin-1  se- 
quences,  the  rat  sequence  con- 
rained  a  BamHI  restriction 
enzyme site, which upon cleavage 
generated a 169-bp fragment and 
a  38-bp  fragment.  The  169-bp 
fragment was used to indicate the 
presence of the rat stromelysin-1 
tranagene.  The  endogenous 
mouse  stromelysin-1  was  not 
cleaved.  Total RNA from rat (R) 
and mouse (M) involuting mam- 
mary glands was used as a posi- 
tive  and  a  negative  control, 
respectively.  For additional  con- 
trois, the reaction was performed without RNA (-) or with total rat RNA (+) but without reverse  transcription. Two different  samples 
were analyzed for 15-d-pregnant  (P), 8-d-lactating  (L), 9-d-lactating/2-d-involuting  (I), and the negative control (-).  Molecular weight 
(xlO  -3) markers are indicated  on the left. 
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mammary tissue from 8-d-lactating mammary glands.  (A) Normal 
mammary tissue incubated with human anti-stromelysin-1  mono- 
clonal antibody. (B) Transgenic  (M2-5) mammary tissue incubated 
with anti-stromelysin-1  monoclonal antibody. (C) Transgenic  (M2- 
5) mammary tissue incubated without the primary stromelysin-1 
antibody.  Stromelysin-1  protein  present  in  transgenic  lactating 
mammary glands but not in normal glands is evident as abundant 
deposits  mainly around smaU convoluted alveoli  in the proximity 
of the basement membrane. In the normal gland a smart amount of 
staining  is seen around a small blood vessel near the center of the 
field.  Bar,  50/Lm. 
toward the basement membrane. It also appeared that the ac- 
tivated ttansgene product accumulated to a greater extent 
than the latent endogenous gene product. Although not all 
areas of the gland stained uniformly for the stromelysin-1 
protein (Fig. 2 B), this pattern of expression is not surpris- 
ing, because endogenous expression of WAP is not uniform 
in the gland (Blackie, L., and M. J. Bissell, unpublished ob- 
servation). 
The Stromelysin-1 Transgene  Behaves Like a 
Morphosen, Increasing Branching Morphogenesis 
and Stimulating Differentiation during Mammary 
Gland Development 
During normal development,  WAP mRNA is detected in 
pregnancy, and reaches a high level by day 16 (Pittius et al., 
1988). It has been assumed that the WAP gene is transcrip- 
tionally  inactive  before this  stage  of development  (Hen- 
nighausen et al., 1991); however, we detected the transgenic 
rat stromelysin-1 mRNA even in nonpregnant mice, albeit at 
a low level. Our data for stromelysin-1 RNA expression led 
us to examine the virgin female gland by using whole-mount 
preparations. 
Branching morphogenesis in the manunary gland is under 
hormonal control of  the ovary. At puberty (about 3 wk of  age 
in mice), the mammary epithelial ceils proliferate, resulting 
in the lengthening and branching of the ductal tree until the 
whole raammary fat pad is filled (Daniel  and Silberstein, 
1987). Glands taken from normal 70-d-old virgin females 
displayed the typical ductal branching pattern of postpuber- 
tal manunary glands  (Fig.  3 A).  However, the mammary 
glands of  the M2-5 and M1-9 transgenic virgin females (Fig. 
3,  B and E,  respectively)  showed precocious maturation, 
with  more branches  from primary  and  secondary ducts 
filling in the spaces in the dactal network. This is similar to 
the morphology of a normal 9-12-day pregnant gland (Fig. 
3 F). In the transgenic mice the frequency of branching, as 
measured by interbranch distance of  the primary ducts, dou- 
bled, and the number of alveolar-like  end buds  increased 
dramatically (Table I).  Examination  of transgenic glands 
from the start of  branching morphogenesis at day 35 until its 
completion at day 70  revealed  that the transgenic  virgin 
phenotype  became apparent between day 40 and day 60, first 
appearing in the most mature areas of  branching,  away from 
the still actively growing areas within terminal end buds, al- 
though the exact timing differed from animal to animal (data 
not shown). This phenotype was not observed in the mam- 
mary glands of male transgenic mice, confirming that WAP 
expression  depends on the presence of female hormones 
(Pittius  et  al.,  1988). In  histological  cross-sections,  the 
increased branching seen in the transgenic  whole-mount 
preparations  was evident as increased numbers of ducts and 
alveolar end buds (compare Fig. 3, C with D). The excess 
branching persisted into pregnancy and was readily apparent 
in wbole-mount  preparations even in midpregnancy  (data not 
shown). 
Our results suggest that the morphology of the developing 
gland is exquisitely sensitive to periceilular proteolysis. The 
increased cellularity present in the transgenic  virgin gland 
was similar to that found in normal glands during early to 
midpregnancy (Fig. 3 F), suggesting that stromelysin-1, di- 
rectly or indirectly, stimulates epithelial cell growth and dif- 
Sympson et ai. Autoactivated Stromelysin-I  Disrupts Mammary Function  685 Figure 3. Structure of  normal and transgenic mouse mammary glands during development. Wh01e-mount  (A, B, E, and F) and hematoxylin- 
eosin-stained sections (C and D) of normal and transgenic mouse msmmm'y glands are shown. (A) Normal 70-d virgin, (B) transgenic 
70-d virgin (M2-5),  (E) transgenic 72-d virgin (M7-9), and (F) normal 12-d-pre~,nant  mammary glands. The dense oval structures seen 
in B and E are lymph nodes. The transgenic virgin mammary glands are highly branched and resemble the morphology of the normal 
12-d-pregnant glands. This increased branching morphology is evident by comparing the hematoxylin and eosin-stained sections Of  normal 
virgin gland (C) with those of M2-5 transgenic gland (D). Bar, ~50/~m. 
ferentiation. We investigated the possibility that the more 
differentiated morphology in the transgenic virgin gland had 
functional  consequence by  examining  the  expression  of 
mRNA for milk proteins. RNA blot analysis showed that the 
glands from transgenic virgin mice, but not those from nor- 
real virgin mice, were highly induced for/~-casein expres- 
sion. ~casein was detected as early as day 40, inparallel 
with the appearance of  the precocious morphological pheno- 
type, arid reached a maximum by day 70 (Fig. 4 A). Although 
the animals are grouped by age, weight is also a factor in the 
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Gland of  Stromelysin-1 Transgenic  Mice 
lnterbranch  Number of alveolar-like 
Age  distance*  buds per 104-p.m  2 
Mice  (days)  (/an)  area  of  gland 
Normal  60  56.1  +  3.7  7.2  5:2.6 
Transgenic*  60  33.4  5-  2.3t  27.8  +  6.9~ 
Normal  70  77.3  +  4.0  7.8  +  4.1 
Transgenic*  70  32.2  5-  2.3J  42.9  +  16.8~ 
For each determination,  four mice were used, and eleven 10L#n~ areas of each 
inguinal gland were scored from whole-mount  ptelna'afions. Values are expressed 
as mean +  SD. 
* Distance  between secondary branches on primary ducts, 
:t Results from SL-M2-5 and M2-21 transgenic lines were pooled. 
§ For all cemparisons between normal and t~msgenic mice, the differences were 
significant (p ~  0.0005;  Student's t test). 
rate  of pubertal development.  Thus, some morphological 
and functional  phenotype could  be  observed as  early  as  day 
40  0ane  2 of  transgenic),  and  was  present  by  day  60  in  most 
animals.  When total  RNA  from glands of  normal pregnant 
mice  was  analyzed,  we found  that  the  transgenic  70-d  virgin 
glands expressed/~-casein  at  a level  similar  to  that  present 
in glands from a normal 9-d-pregnant mouse (Fig.  4 B). 
However, neither  the  transgenic  nor  normal virgin  mice ex- 
pressed endogenous WAP  even at  day 70 of  development. 
The inability  of  the  transgenic  virgin  mice to  express  WAP 
could be a reflection  of  the  normal developmental process 
because WAP  is  expressed at  low levels  prior  to day 16 of 
pregnancy (Pittius  et  al.,  1988) or it  could reflect  the  pres- 
ence of inhibitors  of WAP  synthesis  (Chen and Bissell, 
1989), which exist  in the virgin  gland (Lin,  C. Q., R. J. 
Coffey,  and M. J. Bissell.  1993.  Mol.  Biol. Cell. Suppl. 
4:22a). These data suggest  that  the expression  of  E-casein 
mRNA  correlates  with the extent  of branching morpho- 
genesis. 
Expression of the Stromelysin-1 Transgene 
Affects Expression of the Milk Protein Genes 
during Pregnancy 
By day 14 of pregnancy, mRNA for the full complement of 
milk proteins, including WAP, begins to accumulate in mam- 
mary epithelial ceils at very high levels, and the cells acquire 
a more mature phenotype, becoming lactationally competent 
under appropriate stimuli in culture. To determine whether 
the stromelysin-1  transgene affected this stage of develop- 
ment, we isolated total RNA from whole mammary tissue 
extracts of 15-d-pregnant mice. RNA blot analysis showed 
that mRNA for both/~-casein and WAP was substantially re- 
duced in transgenic mammary glands (Fig. 5 A), suggesting 
that the transgene affected the functional differentiation of 
the gland. Although there were equivalent total cross-sec- 
tional areas of alveoli in normal and transgenic glands (Fig. 
5  C),  the  alveoli of the  transgenic  glands  were  slightly 
smaller, less differentiated in appearance, and lacking in fat 
droplet inclusions. 
To test whether the decrease in expression of/3-casein and 
WAP mRNA in transgenic mice was due to a loss of epithe- 
lial cells, or whether epithelial cells produced less milk pro- 
tein mRNA, we isolated mammary epithelial cells from 15- 
d-pregnant normal and transgenic mice by enzyme digestion 
and separated them from other cell types such as fibroblasts 
Figure 4. Expression of E-casein in normal and transgenic virgin 
mouse mammary glands during development.  RNA (1 #g) from (,4) 
manmmry tissue extracts of normal and transgenic virgin mice at 
various stages  during development  or from (B) mallamary  tissue ex- 
tracts of  normal pregnant  mice was blotted  and hybridized  with 
cDNA  probes for /~-casein  and WAP.  The ethidium  bromide- 
stained  28S band of  total  rRNA is  shown  as  a  control. 
and  adipocytes.  The  concentration  of  both/3-casein  and  WAP 
rnRNA was  substantially  lower in  epithelial  cells  expressing 
the  transgene,  whereas  keratin  18  mRNA,  a  marker  for  epi- 
thelial  cells,  was  similar  in  normal  and  transgenic  mice  (Fig. 
5  B).  This  reduction  in  milk  protein  mRNA  in  mammary ep- 
ithelial  cells  from transgenic  mice paralleled  that  of the 
whole  mammary tissue  from 15-d-pregnant  mice. Thus, the 
activity  of the stromclysin-1  transgene  specifically  affects 
both  the  morphology of  the  mammary gland  and  the  function 
of  the  mannnary epithelial  cells  during pregnancy. 
Expression of the Stromelysin-1 Transgene  Affects 
Basement Membrane Structure and Morphology and 
Ptmction of the Mammary Gland during Lactation 
Endogenous WAP RNA is expressed at the highest levels 
during lactation. To determine whether the inappropriate ex- 
pression of the stromelysin-1  transgene affected the mam- 
mary gland during lactation, we examined lactating mam- 
mary glands from normal and transgenic mice. There were 
distinct differences in alveolar morphology and organization 
between the two.  In the normal gland,  alveoli were well 
rounded and surrounded large lumina (Fig. 6, A and C). In 
Sympson et al. Autoactivated Stromelysin-] Disrupts Mammary Function  687 l~gure 5. Morphology and expression  of E-casein and WAP mRNA in mammary glands of 15-d-pregnant  normal mice (Norm, two lanes 
from different mice) and M2-5 (:/U, left/ane)  and M2-21  (TG, right lane) transgenic  mice. (A) RNA blot (2/~g)  from mammary tissue 
extracts  of 15-d-pregnant  mice. (B) RNA blot (2/~g) from mannnary epithelial  cells  isolated  from 10 pooled mammary glands of 15-d 
normal and of M2-5 and M2-21 transgenic  (TG) pregnant mice. (C) Hematoxylin-eosin-stalned sections of normal and transgenic mam- 
mary glands from 15-d-pregnant  mice.  Bar,  50/zm. 
The Journal of Cell Biology, Volume 125, 1994  688 Figure 6.  Histological  appearance of 8-d-lactating mammary  tissue from normal and transgenic  (M2-2D mice. Paraffin sections were 
stained with hematoxylin and eosin. Compare the well-rounded alveoli with abundant lumina in normal mice (A and C) with the numerous 
convoluted, small alveoli in transgenic mice (B and D). Bars: (,4 and B) 100 ~m; (C and D) 25/ml. 
contrast, most of the alveoli in glands from transgenic mice 
were convoluted,  smaller,  and  in  some cases appeared  to 
have no central lumina  (Fig.  6, B and/9). 
Stromelysin-1 is able to degrade many of the proteins in 
ECM including laminin,  fibronectin, type IV collagen, and 
proteoglycans (Chin et al., 1985). To determine whether the 
expression of the transgene  produced any effects on base- 
ment membrane proteins,  we next investigated the quantity 
and distribution  of basement membrane proteins  in mam- 
mary  glands  from  lactating  normal  and  transgenic  mice. 
There was a striking reduction in the amount of  ECM protein 
extractable from glands of lactating transgenic mice (Fig. 7). 
There were few or no high molecular weight bands corre- 
sponding to laminin and type IV collagen extractable from 
transgenic mouse glands,  as compared with normal mouse 
glands (Fig. 7 A). By immunoblot analysis, mammary gland 
extracts  from  normal  lactating  mice  contained  abundant 
basement membrane laminin  A  and B  chains and type IV 
collagen, whereas these proteins were decreased to 10% or 
less in the transgenic mice (Fig. 7, B and C). By immunocy- 
tochemistry, laminin and type IV collagen (Fig. 8, B and D), 
and fibronectin (data not shown) were distributed in a patchy, 
discontinuous manner around thesmall convoluted alveoli in 
many  areas of the  stromelysin-1  transgenic  mouse glands, 
whereas  continuous  basement  membrane  protein  staining 
was seen under the epithelial  cells of the normal  lactating 
gland (Fig.  8, A and C). 
We next examined the functional consequences of the re- 
duced basement membrane proteins in the lactating  trans- 
genic  mammary  gland  by using  fl-easein  as  a  marker  of 
tissue-specific function. By immunocytochemistry, fl-casein 
was primarily located in the alveolar lumina, with some cel- 
lular staining  (Fig.  8, E  and F).  In areas of the transgenic 
glands in which alveoli had little  imrounoreactive  laminin 
and  type IV  collagen,  the  much  reduced  amounts  of im- 
munoreactive  fl-casein were localized to the  shrunken  lu- 
mina  of the alveoli  (Fig.  8  F).  Although  the  intensity  of 
fl-casein  immunostaining  in  the  lumina  of the  transgenic 
gland was comparable to that in normal lactating tissue (Fig. 
8 E), the cellular staining  was less, and the area was con- 
siderably smaller and resembled an early involuting  gland 
(Talhouk et al.,  1992), rather than a  lactating  gland. 
Discussion 
We used transgenic techniques to directly determine the role 
of ECM in regulating  tissue-specific function in mammary 
gland in vivo. As one approach to gleaning information from 
the  complex,  interactive  system of ECM  components,  we 
chose to target basement membrane generally, but in a tissue- 
specific context. Earlier studies have shown that functional 
perturbation of MMP activity delays manunary gland involu- 
tion:  Implantation  of  slow-release  pellets  containing  the 
MMP inhibitor TIMP-1 into involuting gland generate a halo 
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proteins in mammary glands 
of  transgenic and normal mice. 
(A) Extracts of mammary tis- 
sue  from  normal  and  M2-5 
transgenic  (TG) lactating mice 
were resolved on  12%  SDS- 
polyacrylamide gels. The ar- 
row points to the high molecu- 
lar weight proteins,  most  of 
which are components of the 
basement membrane and ECM 
components.  Molecular weight 
(xl0  -3)  markers  are  also 
shown.  (B and C) Immuno- 
blot analysis of  mammary 
tissue  extracts  shown  in  A. 
Proteins  were  blotted  onto 
Immobilon-P membranes and 
incubated with rabbit  polyclonal  antibodies to mouse laminin (A and B chains) (B) or type IV collagen (al and or2) (C), followed  by incuba- 
tion with alkaline  phosphatase-conjugated  anti-rabbit  IgG. Tissue extract samples were obtained from two different 8-d-lactating  transgenic 
mice; normal tissue extract samples were obtained from 1-d-lactating  mice. The protein pattern seen in normal mice was indistinguishable 
at I  and 8 days of lactation. 
Figure 8. Immunolocalization 
of  laminin,  type  IV collagen, 
and/5-casein  in  lactating  mam- 
mary  glands  of  tranagenic  and 
normal  mice.  Photomicro- 
graphs of  (,4  and B) laminin 
(LM), (C  and/3)  type  IV  col- 
lagen (C/V),  and (E and F) 
#-casein  (Cas)  were  localized 
by  immunofluorescence  in 
8-d-~ctatmg mammary gla-ds 
in normal mice (A, C, and E) 
or M2-21 transgenic mice (B, 
D,  and F).  Note  the patchy 
distribution  of LM and CIV in 
the  basement  membrane  of 
many areas of the tranagenic 
mice, compared with the con- 
tinuous distribution of both of 
these  components  in  normal 
tissue.  8-~:asein  was localized 
in luminal areas in both normal 
(E) and transgenic (F) glands, 
but much more ~-casein was 
present in the normal gland. 
Bar, 50 tim. 
The Journal of Cell Biology,  Volume 125, 1994  690 of functional  alveoli (Talhouk et al., 1992). The time course 
of stromelysin-I  mRNA expression  during  involution corre- 
lates with the loss of tissue-specific  function (Talhouk et al., 
1992; Strange et al., 1992), and immunostaining  shows that 
stromelysin-1  is  highly  expressed  in  myoepithelial  cells 
(Dickson and Warburton, 1992). By in situ hybridization  we 
also find stromelysin-1 expressed in stromal cells (Thomas- 
set, N., C. J. Sympson, Z. Werb, and M. J. Bissell, unpub- 
lished results).  Stromelysin-1  is therefore  a good candidate 
for a functional  regulator of the ECM-mammary cell inter- 
actions. We decided to overexpress this MMP under the con- 
trol of a  mammary-specific promoter,  WAP, to study the 
effect that an enzyme of  broad specificity has on the develop- 
ment and  function of the mammary gland. 
Nothing is known about physiological  activation  of pros- 
tromelysin, although  the enzyme can be activated by a cas- 
cade of serine proteinases (such as plasminogen  activator) 
and  subsequently catalyze an autolytic activation  in vitro 
(Birkedal-Hansen  et al.,  1993; Mignatti  and Rifkin, 1993). 
Therefore,  we chose to use the autoactivating  mutant en- 
zymes to bypass the requirement for a functional  activator. 
Transgenic rat stromelysin-1 mRNA is expressed at a much 
lower  level  than  endogenous  stromelysin-1  RNA  but  is 
clearly morphogenic, suggesting that enzyme activation may 
be critically controlled in developing gland.  Not only does 
stromelysin-1  have a cleavage specificity  that  targets  many 
components of  the ECM, but this enzyme also serves to pro- 
teolytically  activate  other  members  of the  MMP  family 
(Birkexial-Hansen et al.,  1993) and is therefore likely to be 
key as an initiator of a cascade of MMP activity.  Several 
other  MMPs  are  expressed  in  mammary  gland,  notably 
gelatinase  A (72 kD gelatinase)  (Talhouk et al., 1991, 1992; 
Dickson and Warburton,  1992) and stromelysin-3  (Lefebvre 
et al.,  1992). 
The targeted expression of rat stromelysin-1 to mammary 
epithelial ceils led to three distinct phenotypes that depended 
on the stage of development of the mammary gland:  (a) ex- 
cess branching and precocious development in the transgenic 
virgin glands;  (b) reduced tissue-specific  gene expression in 
midpregnancy;  and (c) a discontinuous basement membrane 
and reduction in alveolar size and function during lactation. 
Our data provide direct evidence for the hypothesis that base- 
ment membrane remodeling is central  to the regulation  of 
mammary epithelial cell growth and function during various 
stages (prepuberty, puberty, gestation, lactation,  and involu- 
tion)  of postnatal mammary development and suggest that 
stromelysin-1 has growth-promoting  activity for virgin mam- 
mary epithelial  cells in vivo. 
Hyperplasia of the Transgenic Virgin Gland 
The  postnatal  development  of mammary  epithelium  has 
three distinct  phases:  In the virgin  gland,  postpubertal ste- 
roids instruct ductal expansion  by stimulating  the growth 
of  cells in the bulbous terminal end buds. During the first two 
weeks of pregnancy, smaller side branches develop from the 
major ducts,  their tips differentiating  to form alveolar-like 
structures.  During the final week of pregnancy, the alveolar 
sacs distend and synthesize lipid droplets and milk proteins 
(Knight  and  Peaker,  1982;  Daniel  and  Silberstein,  1987; 
Forsyth,  1991). The virgin  mouse mammary gland  is not 
quiescent but is subject to cyclic stimulation  and regression 
during the estrus cycle. Elegant studies have shown that the 
composition of the basement membrane  of human  gland 
changes at different stages of the menstrual cycle (Ferguson 
et al.,  1992).  Some proteins (for example,  collagens  I, Ill, 
VI,  and  VII)  appear  to  be  stable,  and  others  (laminin, 
fibronectin,  tenascin,  collagens  IV and V) are withdrawn 
and resynthesized  under hormonal instruction. 
In the virgin female, the stromelysin-1 transgene  behaved 
as a morphogen, inducing  the ducts to branch, proliferate, 
and differentiate.  Activation of the WAP-driven transgene is 
likely to derive from a short burst of activation of milk pro- 
tein expression  during  estrus.  Although we do not under- 
stand the mechanism that underlies this morphogenic prop- 
erty of stromelysin-1, there are various possibilities:  (a) loss 
of a growth inhibitor (active  suppression of growth by the 
basement membrane, or proteolytic destruction of  a negative 
cytokine); (b) generation of a growth stimulator,  perhaps by 
fragmentation  of ECM (for example, to reveal cryptic sites 
on critical molecules such as laminin)  or mobilization  of an 
ECM-tethered growth factor. In support of  these ideas, Zhou 
et al.  (1993) described a hyperplastic condition  of human 
smooth muscle cells in vivo that was linked to a deficiency 
of  basement membrane collagen or5 (IV) and 0~6 (IV) chains. 
Furthermore,  many  classes  of growth  factor  have  been 
shown to bind ECM components and are likely to be im- 
mobilized  there.  These  include  fibroblast  growth  factor, 
Writ, TGF-a, and insulin-like growth factor family members 
(Flaumenhaft and Rifkin, 1991; Bernfield et al., 1992; Jones 
et al.,  1993).  Expression of all of these families  is repre- 
sented in developing mammary gland, together with recep- 
tors and effective signaling responses (Gavin and McMahon, 
1992; Sllberstein  et al.,  1992; Fielder et al.,  1992; Shack- 
leford et al.,  1993).  Experiments with transgenic  animals 
have implicated  a number of these growth factors in the de- 
velopmental process (Dickson et al.,  1991). 
The virgin transgenic  glands progress only to the equiva- 
lent of midpregnancy  and do not proliferate or develop be- 
yond that stage (i.e., they do not branch further and do not 
express WAP). It has previously been assumed that WAP is 
not expressed in normal virgin  gland  (Pittius  et al.,  1988; 
Hennighausen,  1991). However, our results clearly indicate 
that the WAP promoter is active in the virgin gland albeit at 
a much lower level. Although/3-casein  is expressed in trans- 
genie virgin mice, WAP is not detected. This indicates  that 
despite the fact that the WAP promoter is active (hence, the 
expression of the transgene  and branching),  the endogenous 
WAP mRNA does not accumulate.  The mechanism of WAP 
mRNA stability is not understood and may relate to the puta- 
tive  soluble inhibitors  of WAP detected in tissue culture 
(Chela and Bissell,  1989). 
Ductal hyperplasia is also observed in mice overexpress- 
ing human growth hormone,  activated  growth factors and 
their  activated  receptors,  and protooncogenes (for review 
see Adams and Cory,  1991). The same pattern is seen in 
transgenic  animals  bearing an MMTV-Wnt-1 construct and 
in epithelial cells transfected with Wnt-1 and grown in recon- 
stituted  glands  (Tsukamoto  et al.,  1988;  Edwards  et al., 
1992).  Writ-1 overexpression  and hyperplasia is succeeded 
by development of numerous manmmry carcinomas.  Dys- 
functional  morphogenesis appears to cause a significant in- 
crease in the rate of  neoplastic lesions. We find that the WAP- 
stromelysin-1  transgenic  lines  are also predisposed to the 
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tions).  We suggest that stromelysin-1 may contribute to the 
transformation  process by causing abnormal patterns of cell 
growth. 
Reduced Tissue-Specific Gene Expression 
in Midpregnancy 
ECM is critical to the synthesis of milk proteins by mam- 
mary epithelial cells in culture (Streuli et al., 1991 and refer- 
ences therein). Detailed studies have attributed the transcrip- 
tional sensitivity of t-casein milk protein to a signal derived 
from the interaction  of laminin  with its cognate receptor 
(Streuli  et al.,  1991; Streuli,  C. H., C. Schmidhauser,  N. 
Bailey, P. Yurchenco, A. Skubitz,  and M. J. Bissell,  manu- 
script  submitted  for publication).  Laminin  has  also been 
identified as a substrate for stromelysin-1 in vitro, as has col- 
lagen IV and entactin (Birkedal-Hansen et al., 1993). The re- 
duced amount of total laminin and collagen IV we observed 
by protein analysis correlated with diminished  expression of 
milk proteins in the transgenic  pregnant  glands.  This result 
would be predicted from the studies of mammary epithelial 
cells in culture and serves to validate these studies as a model 
of physiological  function. 
Because virgin glands show precocious development to a 
stage that  resembles  midpregnancy,  and  pregnant  glands 
show diminished  function,  the transgene  would appear to 
have two opposing effects on development.  The switch in ex- 
pression patterns of ECM and growth factors specified by the 
hormonal regimen characteristic  of pregnancy  is likely  to 
change the growth-response  characteristics  of the ceils, and 
the relative importance of any given stimulus may be com- 
pletely different in the progesterone-independent  and -depen- 
dent states.  The differences  in growth control are also im- 
plied by the very different effects that exogenous TGF-/3 has 
on virgin  and pregnant  gland.  In virgin  gland,  TGF-/3 in- 
hibits  epithelial  growth,  stimulates  mesenchymal  growth, 
and increases ECM synthesis (Daniel et al., 1989). In preg- 
nant  gland,  TGF-B has no effect on epithelial  growth and 
does not affect matrix gene expression  (Silberstein  et al., 
1992). 
Altered Alveolar Morphology and Function 
in Lactation 
The cross-sectional morphology of the transgenic  pregnant 
gland was not radically different  from that  of the normal 
pregnant gland, but the lactating gland showed a clear altera- 
tion. Alveoli were smaller and appeared frequently in tan- 
gential section,  suggesting that they were small spheres and 
unexpanded,  flattened  aiveoli.  WAP expression  increased 
during lactation,  with a parallel increase in expression of the 
transgene.  The role of the ECM in the final dilation,  expan- 
sion, and functional differentiation of alveoli has not been ex- 
plored. The functional  integrity  of the basement membrane 
may be critical  at this  time.  The continuity  of basement 
membrane, visualized by immunostaining,  was maintained 
in the transgenic  pregnant  gland,  presumably as a result of 
continuous synthesis  and deposition of ECM components 
(unpublished  observations).  However,  the integrity  of the 
lamina lapsed in the lactating  gland,  apparent as fraying by 
in situ immunocytochemistry.  At this stage, few ECM com- 
ponents are transcribed, and we surmise that the diminished 
staining  revealed a  loss of ECM generated by transgene- 
dependent proteolysis.  In preliminary  studies, we have criti- 
caUy tested the role of active stromelysin-1 in generating  the 
transgenic  phenotype: we were able to reverse some of the 
stromelysin-1 transgenic  phenotypes by crossing these mice 
with  TIMP-l-overexpressing  transgenic  animals  (unpub- 
lished observations). 
There have been very few examples of the genetic manipu- 
lation of proteinases and inhibitors,  despite their implication 
in both developmental  and pathological  processes (Alex- 
ander and Werb,  1991; Mignatti  and Rifkin,  1993).  Pro- 
teinases  and inhibitors  also alter morphogenesis in vitro: 
Embryonic salivary  glands and lungs  cultured with either 
TIMP-1 or collagenase react by forming more or fewer clefts, 
respectively (Fukuda et al., 1988; Matrisian,  1990). Target- 
ing of human collagenase  to mouse lung by using the hap- 
toglobin promoter generated an emphysema-like phenotype 
(D~rmiento et ai.,  1992). Overexpression  of urokinase  on 
an albumin promoter led to a coagulation  disorder but no 
ECM phenotype (Heckel et al., 1990). When urokinase and 
plasminogen  activator were overexpressed on the WAP pro- 
moter, these two proteinases were secreted into milk with no 
reported consequences on mammary phenotype (Pittius  et 
al.,  1988; Hennighausen  et al.,  1991). Thus, direct tests of 
the role of ECM and proteinases have been very limited. Our 
experiments  allowed us to examine in molecular detail how 
stromelysin-1 works both as a morphogen to generate diverse 
phenotypes at various stages of mammary gland  develop- 
ment and as a regulator of gene expression by disrupting  the 
integrity  of the basement membrane. 
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